Indian American-led health data startup Gliimpse, based in Redwood City, Calif., has been acquired by Apple.
Gliimpse, founded by Anil Sethi and Karthik Hariharan in 2013, allows its users to manage their health records and share them securely with those they trust.
Sethi is a serial entrepreneur who has spent the past decade working with health startups, after taking his company Sequoia Software public in 2000. He got his start as a systems engineer at Apple in the late 1980s.
Sethi, who serves as the company’s chief executive officer, noted on his LinkedIn page that Gliimpse was a way to help his sister, who is battling breast cancer.
“As a consumer of healthcare, I leave behind a bread-crumb-trail of medical info wherever I’ve been seen. But, I'm unable to easily access or share my own data,” he wrote. “Obamacare is one of several forcing functions federally mandating physicians and hospitals give us our data … However, there’s no single Electronic Health Record that all physicians use.”
Gliimpse, according to Crunchbase, has between 11 and 50 employees and had raised roughly $1 million in funding in one round.
The company describes itself as “healthcare’s platform for patient data.”
It unlocks patient data silos, allowing them to aggregate fragmented data into a patient-owned, longitudinal health profile.
It boasts that “Gliimpse is your personal health history, in the palm of your hands.”
Apple acquired the startup earlier in the year, but confirmed it Aug. 22, Fast Company reported. The terms of the acquisition were not disclosed.
Apple officials said the company buys smaller technology companies from time to time but don’t generally discuss the purpose or plan of the acquisitions, according to the Fast Company report.
The acquisition, however, is believed to be a sign of Apple’s growing focus on health and wellbeing. Previously, it has pushed out software HealthKit, CareKit and ResearchKit, which are all health data-based. Meanwhile, the Apple Watch is believed to be more health-oriented in future releases.
What stands out about the deal is that Gliimpse is intended for patients with diseases like cancer and diabetes, the report added. Apple recently hired a top pediatric endocrinologist who developed a HealthKit app for teens with Type 1 diabetes, signaling an increased interest in applications for chronically ill users.
The acquisition is not expected to bring Apple's health technologies under the purview of federal regulators.
Neither company has officially announced the acquisition publicly at press deadline.